These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 15279575
1. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors. Buynak JD. Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575 [Abstract] [Full Text] [Related]
2. Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions. Therrien C, Levesque RC. FEMS Microbiol Rev; 2000 Jul; 24(3):251-62. PubMed ID: 10841972 [Abstract] [Full Text] [Related]
7. Beta-lactamase inhibitors: the story so far. Pérez-Llarena FJ, Bou G. Curr Med Chem; 2009 Dec 15; 16(28):3740-65. PubMed ID: 19747143 [Abstract] [Full Text] [Related]
8. Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition. Bebrone C, Lassaux P, Vercheval L, Sohier JS, Jehaes A, Sauvage E, Galleni M. Drugs; 2010 Apr 16; 70(6):651-79. PubMed ID: 20394454 [Abstract] [Full Text] [Related]
9. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors. Sandanayaka VP, Prashad AS. Curr Med Chem; 2002 Jun 16; 9(12):1145-65. PubMed ID: 12052169 [Abstract] [Full Text] [Related]
10. Beta-lactamase-mediated resistance and opportunities for its control. Livermore DM. J Antimicrob Chemother; 1998 Jun 16; 41 Suppl D():25-41. PubMed ID: 9688449 [Abstract] [Full Text] [Related]
11. Progress toward inhibitors of metallo-β-lactamases. McGeary RP, Tan DT, Schenk G. Future Med Chem; 2017 May 16; 9(7):673-691. PubMed ID: 28504895 [Abstract] [Full Text] [Related]
12. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors. Coleman K. Curr Opin Microbiol; 2011 Oct 16; 14(5):550-5. PubMed ID: 21840248 [Abstract] [Full Text] [Related]
13. Beta-lactam antibiotic resistance: a current structural perspective. Wilke MS, Lovering AL, Strynadka NC. Curr Opin Microbiol; 2005 Oct 16; 8(5):525-33. PubMed ID: 16129657 [Abstract] [Full Text] [Related]
14. Tackling the Antibiotic Resistance Caused by Class A β-Lactamases through the Use of β-Lactamase Inhibitory Protein. Eiamphungporn W, Schaduangrat N, Malik AA, Nantasenamat C. Int J Mol Sci; 2018 Jul 30; 19(8):. PubMed ID: 30061509 [Abstract] [Full Text] [Related]
15. Three decades of beta-lactamase inhibitors. Drawz SM, Bonomo RA. Clin Microbiol Rev; 2010 Jan 30; 23(1):160-201. PubMed ID: 20065329 [Abstract] [Full Text] [Related]
16. New promising β-lactamase inhibitors for clinical use. Olsen I. Eur J Clin Microbiol Infect Dis; 2015 Jul 30; 34(7):1303-8. PubMed ID: 25864193 [Abstract] [Full Text] [Related]
17. Engineered Amp C β-lactamase as a fluorescent screening tool for class C β-lactamase inhibitors. Tsang MW, Chan PH, So PK, Ma DL, Tsang CW, Wong KY, Leung YC. Anal Chem; 2011 Mar 15; 83(6):1996-2004. PubMed ID: 21338058 [Abstract] [Full Text] [Related]
18. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism. Palacios AR, Rossi MA, Mahler GS, Vila AJ. Biomolecules; 2020 Jun 03; 10(6):. PubMed ID: 32503337 [Abstract] [Full Text] [Related]
19. Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential? Devi P, Rutledge PJ. Chembiochem; 2017 Feb 16; 18(4):338-351. PubMed ID: 27992105 [Abstract] [Full Text] [Related]
20. β-Lactamase inhibitors: an update. Chen J, Shang X, Hu F, Lao X, Gao X, Zheng H, Yao W. Mini Rev Med Chem; 2013 Nov 16; 13(13):1846-61. PubMed ID: 23895190 [Abstract] [Full Text] [Related] Page: [Next] [New Search]